Internationally recognized services available through BC Cancer to internal and external researchers and collaborators include the following.

Genome Sciences Centre

Genome Science Centre Collaborative Services

The BC Cancer Genome Sciences Centre (GSC) partners with academic, clinical and industry leaders internationally, and welcomes new collaborations. 

The GSC is now ISO 27001 certified and designed for flexible, efficient, secure, scalable and high-throughput quality analyses, our facilities house cutting-edge sequencing technology and some of the largest and most innovative computing infrastructure in the world.

Services include:

Sequencing Services

The GSC's sequencing platform is recognized internationally.

Our high-throughput, large-scale genome and transcriptome sequencing platform is designed to maximize capacity while maintaining quality, efficiency, scalability and flexibility. We offer several high quality, high throughput targeted sequencing services, including: 

Terry Fox Laboratory

Flow Cytometry

The Flow Cytometry Core Facility (FCCF), is housed in the Terry Fox Laboratory and provides investigators at the British Columbia Cancer Research Centre access to high quality, cost effective flow cytometry services. By providing these services, as well as the scientific expertise necessary to effectively use this technology, the Facility serves to enhance the scope and quality of scientific research performed at the Research Centre. Equipment include staff-operated Cell Sorters (16-colour BD FACSAria Fusion & FACSAria III); user-operated cell sorter (8-colour BD FACSMelody) and cell analyzers (28-colour BD FACSymphony, 16-colour BD Fortessa, 8-colour BD FACSCalibur, 40-channel Fluidigm CyTOF2 mass cytometer, scilVet ABC animal blood differential analyzer, Beckman vi-CELL cell viability analyzer, and etc).

Genetic Modeling Centre

The BC Cancer Center for Genetic Modeling (CGM) was initiated in 2004 as an expansion of the Terry Fox Laboratory Transgenics Core after a decade of successful operations. It is situated within the BC Cancer Research Center (BCCRC) building, which houses a 1,995 m2 rodent facility (ARC) that provides a barrier environment matching the highest standards of pathogen control for commercial facilities around the world. A biohazard Containment Level III facility, an Embryonic Stem (ES) cell lab, and mouse phenotyping suites also exist as infrastructure support for the CGM.

Experimental Therapeutics

Investigational Drug Program

BC Cancer Investigational Drug Program (IDP) provides fee-for-service preclinical research services and contract manufacturing for academic and private sector researchers. IDP’s mandate is to help its research partners develop promising therapeutic compounds to the point where they can be tested in early phase human clinical trials.

Deeley Research Centre

Molecular and Cellular Immunology Core

The Molecular and Cellular Immunology Core (MCIC) is a full service facility specializing in advanced molecular, genomic and histological methods including multicolour immunohistochemistry (mcIHC) and immunofluorescence (mcIF), automated image analysis, laser capture microdissection, multispectral flow cytometry, and single-cell sequencing. 

MCIC supports academic and industry projects both nationally and internationally, ranging from investigator-driven basic research, to correlative studies for clinical trials, to fee-for-service projects with industrial clients.

Back to top